Blog

Bishal Gyawali: Patient perspectives on overtreatment, clinical trials, and quality of life

Bishal Gyawali/scri.queensu.ca

Sep 29, 2024, 17:04

Bishal Gyawali: Patient perspectives on overtreatment, clinical trials, and quality of life

Bishal Gyawali reposted on X:

“This is a brilliant and poignant piece highlighting patient perspectives on overtreatment, clinical trials, and quality of life. I hope many patients read this.”

Source: Bishal Gyawali/X

More posts featuring Bishal Gyawali on oncodaily.com

Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives.

Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.

ASCO’s Health Equity and Outcomes Committee Bishal Gyawali cancer OncoDaily Oncology Queen’s University WHO Essential Medicines List Cancer Medicines Working Group

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage